The Latest Breaking News from Pfizer

‘Continual updating of our vaccinations and booster shots is critical,’ scientists say

Australia has used less than a quarter of the hundreds of millions of COVID-19 vaccine doses it bought. What will happen to the rest?

ORLANDO, Fla. — Scientists have suggested that once vaccines and treatment for COVID-19 became widely available, a surge might not require more than the basic precautions practiced during flu season. With the development of vaccines, pre-exposure treatment such as Evushield and post-exposure treatment such as Paxlovid, it’s natural to ask…

After over two years of COVID-19-induced lockdown, Bhutan will open its doors for tourists on September 23 with a new expensive policy for international tourists and Indians as well. Bhutan Foreign Minister Tandi Dorji says the lessons of COVID-19 include better ties with neighbours, including China.

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 16 strange trades.

ATLANTA — Sesame Street’s Elmo, who is 3½, recently got his COVID-19 vaccine.

A survey of 39,000 people who currently or formerly menstruate found that 42 percent of respondents had irregular or breakthrough bleeding after a COVID vaccine.

Shares of Novavax (NASDAQ: NVAX) fell 26.2% on Jul 14, after the European Medicines Agency's (TSE: EMA) Pharmacovigilance Risk Assessment Committee ("PRAC") updated the product label of Nuvaxovid, the company's COVID-19 vaccine, to include some potential side effects like severe aller

The BA.5 strain represented 65% of cases from July 3 to 9, according to data from the Centers of Disease Control and Prevention.

Omicron is now the dominant strain of COVID-19 around the world and boosters targeting this variant are getting closer to being released.

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 11 strange trades.